PCV50 Cost-Effectiveness Analysis of Treating Acute Coronary Syndrome Patients With Ticagrelor Versus Clopidogrel in Hong Kong: A Markov Analytic Model

Analytic Model ◽

Coronary Syndrome ◽

Cost-Effectiveness Analysis Of Ticagrelor In Treating Patients With Acute Coronary Syndrome In Hong Kong

Value in Health ◽

10.1016/j.jval.2014.08.1430 ◽

2014 ◽

Vol 17 (7) ◽

pp. A487

Author(s):

D.B.C. Wu ◽

B.S.C. Lee ◽

K.K.C. Lee

Keyword(s):

Acute Coronary Syndrome ◽

Hong Kong ◽

Cost Effectiveness ◽

Coronary Syndrome ◽

CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-016-6705-y ◽

2016 ◽

Vol 31 (1) ◽

pp. 39-49 ◽

Cited By ~ 12

Author(s):

Minghuan Jiang ◽

Joyce H. S. You

Keyword(s):

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Antiplatelet Therapy ◽

Coronary Syndrome ◽

PCV83 - KEY MODEL PARAMETERS AND METHODOLOGIES USED IN COST-EFFECTIVENESS ANALYSIS EVALUATING TREATMENTS FOR SECONDARY PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) IN PATIENTS WITH A PRIOR MYOCARDIAL INFARCTION (MI) OR ACUTE CORONARY SYNDROME (ACS)

Value in Health ◽

10.1016/j.jval.2018.09.629 ◽

2018 ◽

Vol 21 ◽

pp. S106

Author(s):

R. Jindal ◽

G. Partha ◽

S. Cholasamudram ◽

J. Cristino

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Secondary Prevention ◽

Cardiovascular Events ◽

Major Adverse Cardiovascular Events ◽

Model Parameters ◽

Coronary Syndrome ◽

Pre-hospital ECG for acute coronary syndrome in urban India: A cost-effectiveness analysis

BMC Cardiovascular Disorders ◽

10.1186/1471-2261-10-13 ◽

2010 ◽

Vol 10 (1) ◽

Cited By ~ 9

Author(s):

Joshua Schulman-Marcus ◽

Dorairaj Prabhakaran ◽

Thomas A Gaziano

Keyword(s):

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Coronary Syndrome ◽

Effectiveness Analysis ◽

Urban India

PCV72 Long-Term Cost Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome from a Polish Health Care Perspective

Value in Health ◽

10.1016/j.jval.2011.08.792 ◽

2011 ◽

Vol 14 (7) ◽

pp. A377 ◽

Cited By ~ 2

Author(s):

T. Macioch ◽

M. Niewada ◽

P. Perkowski ◽

C. Mellström ◽

A. Budaj

Keyword(s):

Health Care ◽

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Coronary Syndrome ◽

Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome

Clinical Cardiology ◽

10.1002/clc.22756 ◽

2017 ◽

Vol 40 (10) ◽

pp. 789-796 ◽

Cited By ~ 4

Author(s):

Minghuan Jiang ◽

Joyce H.S. You

Keyword(s):

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Antiplatelet Therapy ◽

Dual Antiplatelet Therapy ◽

Drug Eluting Stents ◽

Coronary Syndrome ◽

Effectiveness Analysis ◽

Drug Eluting

Clopidogrel Versus Aspirin For The Treatment Of Acute Coronary Syndrome After A 12-Month Dual Antiplatelet Therapy: A Cost-Effectiveness Analysis From China Payer’s Perspective

Value in Health ◽

10.1016/j.jval.2018.04.364 ◽

2018 ◽

Vol 21 ◽

pp. S60

Author(s):

L Zhang ◽

Z Lin ◽

H Yin ◽

J Liu ◽

J Xuan

Keyword(s):

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Antiplatelet Therapy ◽

Dual Antiplatelet Therapy ◽

Coronary Syndrome ◽

CV1 - A COST-EFFECTIVENESS ANALYSIS OF MULITI-GENE PHARMACOGENETIC TESTING IN ACUTE CORONARY SYNDROME PATIENTS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION

Value in Health ◽

10.1016/j.jval.2018.09.032 ◽

2018 ◽

Vol 21 ◽

pp. S6

Author(s):

O. Dong ◽

C.R. Lee ◽

S.B. Wheeler ◽

D. Voora ◽

S.B. Dusetzina ◽

...

Keyword(s):

Percutaneous Coronary Intervention ◽

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Coronary Intervention ◽

Pharmacogenetic Testing ◽

Coronary Syndrome ◽

Effectiveness Analysis ◽

Percutaneous Coronary

CV5 SHORT AND LONG TERM COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT S T-SEGMENT ELEVATION (ACS) IN SCANDINAVIAN COUNTRIES

Value in Health ◽

10.1016/s1098-3015(10)61595-1 ◽

2003 ◽

Vol 6 (6) ◽

pp. 621 ◽

Cited By ~ 7

Author(s):

P Lindgren ◽

B Jönsson ◽

J Spiesser ◽

P Carita ◽

S Gabriel

Keyword(s):

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Coronary Syndrome ◽

Effectiveness Analysis ◽

Short And Long Term

Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in Thailand

Heart Lung and Circulation ◽

10.1016/j.hlc.2015.02.018 ◽

2015 ◽

Vol 24 (9) ◽

pp. 860-868 ◽

Cited By ~ 3

Author(s):

Unchalee Permsuwan ◽

Nathorn Chaiyakunapruk ◽

Surakit Nathisuwan ◽

Apichard Sukonthasarn

Keyword(s):

Acute Coronary Syndrome ◽

Cost Effectiveness ◽

Coronary Syndrome ◽

Effectiveness Analysis ◽

St Elevation ◽

Elevation Acute Coronary Syndrome